A Bioequivalence Study of Tobradex AF

Completed · Phase 3

Conditions studied: Cataract

In brief

The purpose of the study is to determine the amount of study medication that moves from the front of the eye into the fluid at the front of the inside of the eye.

Key facts

Study ID

NCT00362895

Run by

Alcon Research

People needed

995

Starts

2006-04-01

Expected to finish

2006-08-01

Last updated by the study team

2012-03-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 or older
• Other protocol-defined inclusion criteria may apply

You may not qualify if…

• Under 18
• Other protocol-defined exclusion criteria may apply

Where it is running

• Contact Alcon for Trial Location(s) — Fort Worth, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.